Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Contract research news in brief

July 27, 2011 Research and Development research and development news

PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
News

BMS makes $325m biotech acquisition

July 25, 2011 Research and Development, Sales and Marketing BMS, biotech, research and development news

Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
News

Sanofi bags GSK’s Anne Whitaker for US role

July 25, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi has appointed Anne Whitaker president of its US pharmaceutical operations. She joins the company from GlaxoSmithKline, where she served …
Appointment
Eli Lilly & Co

Lilly presents data on failed Alzheimer’s candidate

July 21, 2011 Research and Development Alzheimer's disease, lilly, research and development news, semagacestat

Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …
News

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011 Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …
Feature

Future of AZ-BMS diabetes drug in doubt

July 20, 2011 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
News

Contract research news in brief

July 20, 2011 Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
News
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011 Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
Feature

Lophius Biosciences expands management team

July 15, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …
Appointment

France cleans up regulation – and restricts pharma role

July 14, 2011 Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
News

Paul Barrow joins CiToxLAB

July 14, 2011 Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …
Appointment

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011 Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
News
US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011 Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
News
Amgen

Amgen collaborates on cancer antibody research

July 13, 2011 Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
News
clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011 Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025